Literature DB >> 21255085

Adipokines and psoriasis.

Sascha Gerdes1, Martin Rostami-Yazdi, Ulrich Mrowietz.   

Abstract

Adipose tissue is an active endocrine organ contributing to the regulation of multiple metabolic pathways via self-produced bioactive products called adipokines. These adipokines are key players in the pathogenesis of metabolic syndrome and cardiovascular diseases. Co-occurrence of obesity and psoriasis could lead to interactions of both diseases in which adipokines, at least in part, are involved and may contribute to associated comorbidities of psoriasis. Until today numerous adipokines have been identified of which the most important ones are discussed in the following within the context of obesity, chronic inflammation and their possible role in the pathogenesis of psoriasis. Adipokines could serve as a missing link in the causal relationship between psoriasis and comorbidities and may provide a biomarker for disease severity, risk of comorbidities and treatment success.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21255085     DOI: 10.1111/j.1600-0625.2010.01210.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  41 in total

Review 1.  Non-alcoholic fatty liver disease and psoriasis: So far, so near.

Authors:  Giulia Ganzetti; Anna Campanati; Annamaria Offidani
Journal:  World J Hepatol       Date:  2015-03-27

Review 2.  [Comorbidities and psoriasis. Impact on clinical practice].

Authors:  S Gerdes; U Mrowietz
Journal:  Hautarzt       Date:  2012-03       Impact factor: 0.751

3.  Retinol Binding Protein 4 in Non Obese Psoriatic Cases.

Authors:  Ola Ahmed Bakry; Mohamed Abdel Moneim Shoeib; Iman Masoud Abdel Gayed; Amany Said El Menoufy
Journal:  J Clin Diagn Res       Date:  2016-08-01

Review 4.  Genetic markers for cardiovascular disease in psoriasis: the missing piece.

Authors:  Tiago Torres; Andrea Chiricozzi; Sergio Chimenti; Rosita Saraceno
Journal:  Mol Diagn Ther       Date:  2014-02       Impact factor: 4.074

5.  Proinflammatory and anti-inflammatory cytokine profiles in psoriasis: use as laboratory biomarkers and disease predictors.

Authors:  Camila Cataldi; Naiara Lourenço Mari; Marcell Alysson Batisti Lozovoy; Ligia Márcia Mário Martins; Edna Maria Vissoci Reiche; Michael Maes; Isaias Dichi; Andréa Name Colado Simão
Journal:  Inflamm Res       Date:  2019-05-06       Impact factor: 4.575

Review 6.  Does treatment of psoriasis reduce the risk of cardiovascular disease?

Authors:  Sarah Churton; Liza Brown; Thuzar M Shin; Neil J Korman
Journal:  Drugs       Date:  2014-02       Impact factor: 9.546

Review 7.  The Role of Adipocytes in Tissue Regeneration and Stem Cell Niches.

Authors:  Brett Shook; Guillermo Rivera Gonzalez; Sarah Ebmeier; Gabriella Grisotti; Rachel Zwick; Valerie Horsley
Journal:  Annu Rev Cell Dev Biol       Date:  2016-05-04       Impact factor: 13.827

8.  Obesity and risk of incident psoriatic arthritis in US women.

Authors:  Wenqing Li; Jiali Han; Abrar A Qureshi
Journal:  Ann Rheum Dis       Date:  2012-05-05       Impact factor: 19.103

9.  Autoantibody induction and adipokine levels in patients with psoriasis treated with infliximab.

Authors:  Viviana Lora; Chiara Bonaguri; Paolo Gisondi; Franca Sandei; Luisita Battistelli; Annalisa Russo; Alessandra Melegari; Tommaso Trenti; Giuseppe Lippi; Giampiero Girolomoni
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

10.  Lifestyle changes for treating psoriasis.

Authors:  Shu-Hua Ko; Ching-Chi Chi; Mei-Ling Yeh; Shu-Hui Wang; Yu-Shiun Tsai; Mei-Ya Hsu
Journal:  Cochrane Database Syst Rev       Date:  2019-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.